Literature DB >> 7535095

Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes.

S Yonehara1, Y Nishimura, S Kishil, M Yonehara, K Takazawa, T Tamatani, A Ishii.   

Abstract

Apoptosis appears to play a major role in the differentiation and selection of T and B lymphocytes, but the mechanisms of clonal deletion of T cells in thymus are not well understood. We have prepared an anti-human Fas IgM mAb with associated apoptosis-inducing activity in Fas antigen-positive target cells including human T cells. We analyzed the expression of apoptosis antigen Fas on human thymocytes by cytofluorometry showing low, but significant amounts of Fas antigen on double-negative and double-positive undifferentiated thymocytes. On the contrary, most of the differentiated thymocytes (single-positive or CD3-brightest) expressed undetectable levels of Fas antigen. About 1-2% of thymocytes expressed high amounts of Fas antigen, and these cells, which were CD3-bright, were CD4-bright and CD8-low at the stage of late double-positive lineage. Immunohistological analysis shows these Fas-bright cells on the edge of the medulla. Stimulation through the TCR complex was shown to induce the expression of Fas antigen on thymocytes at the late double-positive stage and prolonged stimulation through the TCR complex rendered the Fas-bright thymocytes sensitive to apoptosis-inducing activity of anti-Fas. To show the involvement of the Fas system in the negative selection/clonal deletion of thymocytes, we organ-cultured human thymus in the presence of the superantigen, staphylococcus enterotoxin B (SEB), and new antagonistic anti-Fas mAb, which can inhibit the apoptosis-inducing activity of the original anti-Fas mAb. The SEB-reactive TCR complex on thymocytes was at first down-regulated by SEB, then the SEB-reactive clone was deleted by apoptosis, which was inhibited by an antagonistic anti-Fas mAb. Thus, Fas antigen is shown to be involved in the negative selection/clonal deletion of superantigen-reactive thymocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535095     DOI: 10.1093/intimm/6.12.1849

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  Fas-Fas ligand system as a possible mediator of spermatogenic cell apoptosis in human maturation-arrested testes.

Authors:  Jiro Eguchi; Takehiko Koji; Koichiro Nomata; Akira Yoshii; Masashi Shin; Hiroshi Kanetake
Journal:  Hum Cell       Date:  2002-03       Impact factor: 4.174

2.  Nitric oxide regulates clonal expansion and activation-induced cell death triggered by staphylococcal enterotoxin B.

Authors:  A Brás; L Rodríguez-Borlado; A González-Garcia; C Martínez-A
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

3.  Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress.

Authors:  M Oka; K Hirazawa; K Yamamoto; N Iizuka; S Hazama; T Suzuki; N Kobayashi
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

Review 4.  The Fas counterattack: a molecular mechanism of tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

5.  Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes.

Authors:  A K Simon; O Williams; J Mongkolsapaya; B Jin; X N Xu; H Walczak; G R Screaton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

6.  The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis.

Authors:  A Bordron; M Dueymes; Y Levy; C Jamin; J P Leroy; J C Piette; Y Shoenfeld; P Y Youinou
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

7.  A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis.

Authors:  V Kolesnitchenko; L King; A Riva; Y Tani; S J Korsmeyer; D I Cohen
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.

Authors:  P J Norris; M Sumaroka; C Brander; H F Moffett; S L Boswell; T Nguyen; Y Sykulev; B D Walker; E S Rosenberg
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells.

Authors:  A L Wagelie-Steffen; K Hartmann; H Vliagoftis; D D Metcalfe
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

10.  Cross-linking of Fas by antibodies to a peculiar domain of gp120 V3 loop can enhance T cell apoptosis in HIV-1-infected patients.

Authors:  F Silvestris; S Nagata; P Cafforio; N Silvestris; F Dammacco
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.